#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Patient Assessment
1-1	0-2	4.	_	_	_	_
1-2	3-10	Patient	person|abstract[2]	new|new[2]	coref	5-10
1-3	11-21	Assessment	abstract[2]	new[2]	_	_

#Text=Patients with PE may be uncomfortable discussing their ejaculatory disorder and as such may avoid seeking treatment .
2-1	22-30	Patients	person[3]	new[3]	ana	2-8[0_3]
2-2	31-35	with	person[3]	new[3]	_	_
2-3	36-38	PE	person[3]|abstract	new[3]|new	coref	16-9
2-4	39-42	may	_	_	_	_
2-5	43-45	be	_	_	_	_
2-6	46-59	uncomfortable	_	_	_	_
2-7	60-70	discussing	_	_	_	_
2-8	71-76	their	person|abstract[6]	giv|new[6]	ana|coref	3-1[0_6]|4-18
2-9	77-88	ejaculatory	abstract[6]	new[6]	_	_
2-10	89-97	disorder	abstract[6]	new[6]	_	_
2-11	98-101	and	_	_	_	_
2-12	102-104	as	_	_	_	_
2-13	105-109	such	_	_	_	_
2-14	110-113	may	_	_	_	_
2-15	114-119	avoid	_	_	_	_
2-16	120-127	seeking	_	_	_	_
2-17	128-137	treatment	abstract	new	coref	13-9
2-18	138-139	.	_	_	_	_

#Text=It is therefore important that clinicians establish sexual health as a routine topic during consultations .
3-1	140-142	It	abstract	giv	_	_
3-2	143-145	is	_	_	_	_
3-3	146-155	therefore	_	_	_	_
3-4	156-165	important	_	_	_	_
3-5	166-170	that	_	_	_	_
3-6	171-181	clinicians	person	new	coref	20-4
3-7	182-191	establish	_	_	_	_
3-8	192-198	sexual	abstract[10]	new[10]	coref	4-9[15_10]
3-9	199-205	health	abstract[10]	new[10]	_	_
3-10	206-208	as	_	_	_	_
3-11	209-210	a	abstract[11]	new[11]	coref	8-16[45_11]
3-12	211-218	routine	abstract[11]	new[11]	_	_
3-13	219-224	topic	abstract[11]	new[11]	_	_
3-14	225-231	during	_	_	_	_
3-15	232-245	consultations	event	new	_	_
3-16	246-247	.	_	_	_	_

#Text=One common approach of initiating the conversation about sexual health , and to determine intervention levels for patients , is the PLISSIT Model , first introduced by Annon .
4-1	248-251	One	abstract[13]	new[13]	coref	4-21[20_13]
4-2	252-258	common	abstract[13]	new[13]	_	_
4-3	259-267	approach	abstract[13]	new[13]	_	_
4-4	268-270	of	abstract[13]	new[13]	_	_
4-5	271-281	initiating	abstract[13]	new[13]	_	_
4-6	282-285	the	abstract[13]|event[14]	new[13]|new[14]	coref	7-19[40_14]
4-7	286-298	conversation	abstract[13]|event[14]	new[13]|new[14]	_	_
4-8	299-304	about	abstract[13]|event[14]	new[13]|new[14]	_	_
4-9	305-311	sexual	abstract[13]|event[14]|abstract[15]	new[13]|new[14]|giv[15]	coref	6-26[35_15]
4-10	312-318	health	abstract[13]|event[14]|abstract[15]	new[13]|new[14]|giv[15]	_	_
4-11	319-320	,	abstract[13]	new[13]	_	_
4-12	321-324	and	abstract[13]	new[13]	_	_
4-13	325-327	to	abstract[13]	new[13]	_	_
4-14	328-337	determine	abstract[13]	new[13]	_	_
4-15	338-350	intervention	abstract[13]|event|abstract[17]	new[13]|new|new[17]	coref	5-9[25_17]
4-16	351-357	levels	abstract[13]|abstract[17]	new[13]|new[17]	_	_
4-17	358-361	for	abstract[13]|abstract[17]	new[13]|new[17]	_	_
4-18	362-370	patients	abstract[13]|abstract[17]|person	new[13]|new[17]|giv	ana	6-26
4-19	371-372	,	_	_	_	_
4-20	373-375	is	_	_	_	_
4-21	376-379	the	abstract[20]	giv[20]	coref	5-1[22_20]
4-22	380-387	PLISSIT	abstract|abstract[20]	new|giv[20]	_	_
4-23	388-393	Model	abstract[20]	giv[20]	_	_
4-24	394-395	,	abstract[20]	giv[20]	_	_
4-25	396-401	first	abstract[20]	giv[20]	_	_
4-26	402-412	introduced	abstract[20]	giv[20]	_	_
4-27	413-415	by	abstract[20]	giv[20]	_	_
4-28	416-421	Annon	abstract[20]|person	giv[20]|new	_	_
4-29	422-423	.	_	_	_	_

#Text=This model is a stage-wise approach , and individual patient levels should be identified by the clinician .
5-1	424-428	This	abstract[22]	giv[22]	coref	5-4[23_22]
5-2	429-434	model	abstract[22]	giv[22]	_	_
5-3	435-437	is	_	_	_	_
5-4	438-439	a	abstract[23]	giv[23]	_	_
5-5	440-450	stage-wise	abstract[23]	giv[23]	_	_
5-6	451-459	approach	abstract[23]	giv[23]	_	_
5-7	460-461	,	_	_	_	_
5-8	462-465	and	_	_	_	_
5-9	466-476	individual	abstract[25]	giv[25]	_	_
5-10	477-484	patient	person|abstract[25]	giv|giv[25]	coref	8-8[43_0]
5-11	485-491	levels	abstract[25]	giv[25]	_	_
5-12	492-498	should	_	_	_	_
5-13	499-501	be	_	_	_	_
5-14	502-512	identified	_	_	_	_
5-15	513-515	by	_	_	_	_
5-16	516-519	the	person[26]	new[26]	coref	6-10[30_26]
5-17	520-529	clinician	person[26]	new[26]	_	_
5-18	530-531	.	_	_	_	_

#Text=Permission : This is the first stage in which the clinician gives the client permission to feel comfortable about and discuss a particular facet of their sexual health .
6-1	532-542	Permission	abstract	new	ana	6-3
6-2	543-544	:	_	_	_	_
6-3	545-549	This	abstract	giv	coref	6-5[29_0]
6-4	550-552	is	_	_	_	_
6-5	553-556	the	abstract[29]	giv[29]	coref	6-15[32_29]
6-6	557-562	first	abstract[29]	giv[29]	_	_
6-7	563-568	stage	abstract[29]	giv[29]	_	_
6-8	569-571	in	abstract[29]	giv[29]	_	_
6-9	572-577	which	abstract[29]	giv[29]	_	_
6-10	578-581	the	abstract[29]|person[30]	giv[29]|giv[30]	coref	7-4[37_30]
6-11	582-591	clinician	abstract[29]|person[30]	giv[29]|giv[30]	_	_
6-12	592-597	gives	abstract[29]	giv[29]	_	_
6-13	598-601	the	abstract[29]|person[31]	giv[29]|new[31]	_	_
6-14	602-608	client	abstract[29]|person[31]	giv[29]|new[31]	_	_
6-15	609-619	permission	abstract[29]|abstract[32]	giv[29]|giv[32]	coref	8-5[42_32]
6-16	620-622	to	abstract[29]|abstract[32]	giv[29]|giv[32]	_	_
6-17	623-627	feel	abstract[29]|abstract[32]	giv[29]|giv[32]	_	_
6-18	628-639	comfortable	abstract[29]|abstract[32]	giv[29]|giv[32]	_	_
6-19	640-645	about	abstract[29]|abstract[32]	giv[29]|giv[32]	_	_
6-20	646-649	and	abstract[29]|abstract[32]	giv[29]|giv[32]	_	_
6-21	650-657	discuss	abstract[29]|abstract[32]	giv[29]|giv[32]	_	_
6-22	658-659	a	abstract[29]|abstract[32]|abstract[33]	giv[29]|giv[32]|new[33]	_	_
6-23	660-670	particular	abstract[29]|abstract[32]|abstract[33]	giv[29]|giv[32]|new[33]	_	_
6-24	671-676	facet	abstract[29]|abstract[32]|abstract[33]	giv[29]|giv[32]|new[33]	_	_
6-25	677-679	of	abstract[29]|abstract[32]|abstract[33]	giv[29]|giv[32]|new[33]	_	_
6-26	680-685	their	abstract[29]|abstract[32]|abstract[33]|person|abstract[35]	giv[29]|giv[32]|new[33]|giv|giv[35]	ana|ana	7-1[0_35]|9-20
6-27	686-692	sexual	abstract[29]|abstract[32]|abstract[33]|abstract[35]	giv[29]|giv[32]|new[33]|giv[35]	_	_
6-28	693-699	health	abstract[29]|abstract[32]|abstract[33]|abstract[35]	giv[29]|giv[32]|new[33]|giv[35]	_	_
6-29	700-701	.	_	_	_	_

#Text=It is imperative the clinician maintains a professional , non-judgmental attitude during this time in order to facilitate the conversation .
7-1	702-704	It	abstract	giv	coref	9-20[53_0]
7-2	705-707	is	_	_	_	_
7-3	708-718	imperative	_	_	_	_
7-4	719-722	the	person[37]	giv[37]	coref	9-8[49_37]
7-5	723-732	clinician	person[37]	giv[37]	_	_
7-6	733-742	maintains	_	_	_	_
7-7	743-744	a	abstract[38]	new[38]	_	_
7-8	745-757	professional	abstract[38]	new[38]	_	_
7-9	758-759	,	abstract[38]	new[38]	_	_
7-10	760-774	non-judgmental	abstract[38]	new[38]	_	_
7-11	775-783	attitude	abstract[38]	new[38]	_	_
7-12	784-790	during	_	_	_	_
7-13	791-795	this	time[39]	new[39]	_	_
7-14	796-800	time	time[39]	new[39]	_	_
7-15	801-803	in	_	_	_	_
7-16	804-809	order	_	_	_	_
7-17	810-812	to	_	_	_	_
7-18	813-823	facilitate	_	_	_	_
7-19	824-827	the	event[40]	giv[40]	_	_
7-20	828-840	conversation	event[40]	giv[40]	_	_
7-21	841-842	.	_	_	_	_

#Text=Limited Information : In this stage , the patient is provided with limited information about a topic or issue .
8-1	843-850	Limited	abstract[41]	new[41]	_	_
8-2	851-862	Information	abstract[41]	new[41]	_	_
8-3	863-864	:	_	_	_	_
8-4	865-867	In	_	_	_	_
8-5	868-872	this	abstract[42]	giv[42]	coref	9-5[48_42]
8-6	873-878	stage	abstract[42]	giv[42]	_	_
8-7	879-880	,	_	_	_	_
8-8	881-884	the	person[43]	giv[43]	coref	9-14[51_43]
8-9	885-892	patient	person[43]	giv[43]	_	_
8-10	893-895	is	_	_	_	_
8-11	896-904	provided	_	_	_	_
8-12	905-909	with	_	_	_	_
8-13	910-917	limited	abstract[44]	new[44]	coref	9-25[54_44]
8-14	918-929	information	abstract[44]	new[44]	_	_
8-15	930-935	about	abstract[44]	new[44]	_	_
8-16	936-937	a	abstract[44]|abstract[45]	new[44]|giv[45]	coref	12-9[66_45]
8-17	938-943	topic	abstract[44]|abstract[45]	new[44]|giv[45]	_	_
8-18	944-946	or	abstract[44]	new[44]	_	_
8-19	947-952	issue	abstract[44]|abstract	new[44]|new	ana	9-1
8-20	953-954	.	_	_	_	_

#Text=It is important in this stage that the clinician learns about specific topics the patient wishes to discuss surrounding their sexual health and provide information for the specific subject .
9-1	955-957	It	abstract	giv	coref	14-20[78_0]
9-2	958-960	is	_	_	_	_
9-3	961-970	important	_	_	_	_
9-4	971-973	in	_	_	_	_
9-5	974-978	this	abstract[48]	giv[48]	_	_
9-6	979-984	stage	abstract[48]	giv[48]	_	_
9-7	985-989	that	_	_	_	_
9-8	990-993	the	person[49]	giv[49]	coref	11-3[57_49]
9-9	994-1003	clinician	person[49]	giv[49]	_	_
9-10	1004-1010	learns	_	_	_	_
9-11	1011-1016	about	_	_	_	_
9-12	1017-1025	specific	abstract[50]	new[50]	coref	11-11[60_50]
9-13	1026-1032	topics	abstract[50]	new[50]	_	_
9-14	1033-1036	the	abstract[50]|person[51]	new[50]|giv[51]	coref	11-16[61_51]
9-15	1037-1044	patient	abstract[50]|person[51]	new[50]|giv[51]	_	_
9-16	1045-1051	wishes	abstract[50]	new[50]	_	_
9-17	1052-1054	to	abstract[50]	new[50]	_	_
9-18	1055-1062	discuss	abstract[50]	new[50]	_	_
9-19	1063-1074	surrounding	abstract[50]	new[50]	_	_
9-20	1075-1080	their	abstract[50]|person|abstract[53]	new[50]|giv|giv[53]	coref|coref	11-6|11-15[62_53]
9-21	1081-1087	sexual	abstract[50]|abstract[53]	new[50]|giv[53]	_	_
9-22	1088-1094	health	abstract[50]|abstract[53]	new[50]|giv[53]	_	_
9-23	1095-1098	and	_	_	_	_
9-24	1099-1106	provide	_	_	_	_
9-25	1107-1118	information	abstract[54]	giv[54]	coref	13-1[0_54]
9-26	1119-1122	for	abstract[54]	giv[54]	_	_
9-27	1123-1126	the	abstract[54]|abstract[55]	giv[54]|new[55]	_	_
9-28	1127-1135	specific	abstract[54]|abstract[55]	giv[54]|new[55]	_	_
9-29	1136-1143	subject	abstract[54]|abstract[55]	giv[54]|new[55]	_	_
9-30	1144-1145	.	_	_	_	_

#Text=Specific Suggestion :
10-1	1146-1154	Specific	abstract[56]	new[56]	_	_
10-2	1155-1165	Suggestion	abstract[56]	new[56]	_	_
10-3	1166-1167	:	_	_	_	_

#Text=Here , the clinician provides patients with specific advice on particular topics relating to the patient ’s sexual health .
11-1	1168-1172	Here	_	_	_	_
11-2	1173-1174	,	_	_	_	_
11-3	1175-1178	the	person[57]	giv[57]	coref	29-25[170_57]
11-4	1179-1188	clinician	person[57]	giv[57]	_	_
11-5	1189-1197	provides	_	_	_	_
11-6	1198-1206	patients	person	giv	coref	17-9
11-7	1207-1211	with	_	_	_	_
11-8	1212-1220	specific	abstract[59]	new[59]	_	_
11-9	1221-1227	advice	abstract[59]	new[59]	_	_
11-10	1228-1230	on	abstract[59]	new[59]	_	_
11-11	1231-1241	particular	abstract[59]|abstract[60]	new[59]|giv[60]	_	_
11-12	1242-1248	topics	abstract[59]|abstract[60]	new[59]|giv[60]	_	_
11-13	1249-1257	relating	abstract[59]|abstract[60]	new[59]|giv[60]	_	_
11-14	1258-1260	to	abstract[59]|abstract[60]	new[59]|giv[60]	_	_
11-15	1261-1264	the	abstract[59]|abstract[60]|abstract[62]	new[59]|giv[60]|giv[62]	ana	12-1[0_62]
11-16	1265-1272	patient	abstract[59]|abstract[60]|person[61]|abstract[62]	new[59]|giv[60]|giv[61]|giv[62]	coref	12-6[0_61]
11-17	1273-1275	’s	abstract[59]|abstract[60]|person[61]|abstract[62]	new[59]|giv[60]|giv[61]|giv[62]	_	_
11-18	1276-1282	sexual	abstract[59]|abstract[60]|abstract[62]	new[59]|giv[60]|giv[62]	_	_
11-19	1283-1289	health	abstract[59]|abstract[60]|abstract[62]	new[59]|giv[60]|giv[62]	_	_
11-20	1290-1291	.	_	_	_	_

#Text=This is completed after full patient evaluation surrounding the topic .
12-1	1292-1296	This	abstract	giv	coref	14-29[81_0]
12-2	1297-1299	is	_	_	_	_
12-3	1300-1309	completed	_	_	_	_
12-4	1310-1315	after	_	_	_	_
12-5	1316-1320	full	event[65]	new[65]	_	_
12-6	1321-1328	patient	person|event[65]	giv|new[65]	coref	14-11[76_0]
12-7	1329-1339	evaluation	event[65]	new[65]	_	_
12-8	1340-1351	surrounding	event[65]	new[65]	_	_
12-9	1352-1355	the	event[65]|abstract[66]	new[65]|giv[66]	_	_
12-10	1356-1361	topic	event[65]|abstract[66]	new[65]|giv[66]	_	_
12-11	1362-1363	.	_	_	_	_

#Text=Information includes suggested behavioural changes as well as treatment options for a specific concern .
13-1	1364-1375	Information	abstract	giv	_	_
13-2	1376-1384	includes	_	_	_	_
13-3	1385-1394	suggested	abstract[68]|abstract[69]	new[68]|new[69]	ana	14-29[0_69]
13-4	1395-1406	behavioural	abstract[68]|abstract[69]	new[68]|new[69]	_	_
13-5	1407-1414	changes	abstract[68]|abstract[69]	new[68]|new[69]	_	_
13-6	1415-1417	as	abstract[69]	new[69]	_	_
13-7	1418-1422	well	abstract[69]	new[69]	_	_
13-8	1423-1425	as	abstract[69]	new[69]	_	_
13-9	1426-1435	treatment	abstract[69]|abstract|abstract[71]	new[69]|giv|new[71]	coref	15-9[85_0]
13-10	1436-1443	options	abstract[69]|abstract[71]	new[69]|new[71]	_	_
13-11	1444-1447	for	abstract[69]|abstract[71]	new[69]|new[71]	_	_
13-12	1448-1449	a	abstract[69]|abstract[71]|abstract[72]	new[69]|new[71]|new[72]	_	_
13-13	1450-1458	specific	abstract[69]|abstract[71]|abstract[72]	new[69]|new[71]|new[72]	_	_
13-14	1459-1466	concern	abstract[69]|abstract[71]|abstract[72]	new[69]|new[71]|new[72]	_	_
13-15	1467-1468	.	_	_	_	_

#Text=Intensive Therapy : This is the last stage in which the patient begins psychological and/or pharmacological therapy to remediate a specific issue the patient is suffering from regarding their sexual health .
14-1	1469-1478	Intensive	abstract[73]	new[73]	ana	14-4[0_73]
14-2	1479-1486	Therapy	abstract[73]	new[73]	_	_
14-3	1487-1488	:	_	_	_	_
14-4	1489-1493	This	abstract	giv	coref	14-6[75_0]
14-5	1494-1496	is	_	_	_	_
14-6	1497-1500	the	abstract[75]	giv[75]	coref	14-14[77_75]
14-7	1501-1505	last	abstract[75]	giv[75]	_	_
14-8	1506-1511	stage	abstract[75]	giv[75]	_	_
14-9	1512-1514	in	abstract[75]	giv[75]	_	_
14-10	1515-1520	which	abstract[75]	giv[75]	_	_
14-11	1521-1524	the	abstract[75]|person[76]	giv[75]|giv[76]	coref	14-23[79_76]
14-12	1525-1532	patient	abstract[75]|person[76]	giv[75]|giv[76]	_	_
14-13	1533-1539	begins	abstract[75]	giv[75]	_	_
14-14	1540-1553	psychological	abstract[75]|abstract[77]	giv[75]|giv[77]	coref	32-33[0_77]
14-15	1554-1560	and/or	abstract[75]|abstract[77]	giv[75]|giv[77]	_	_
14-16	1561-1576	pharmacological	abstract[75]|abstract[77]	giv[75]|giv[77]	_	_
14-17	1577-1584	therapy	abstract[75]|abstract[77]	giv[75]|giv[77]	_	_
14-18	1585-1587	to	abstract[75]|abstract[77]	giv[75]|giv[77]	_	_
14-19	1588-1597	remediate	abstract[75]|abstract[77]	giv[75]|giv[77]	_	_
14-20	1598-1599	a	abstract[75]|abstract[77]|abstract[78]	giv[75]|giv[77]|giv[78]	_	_
14-21	1600-1608	specific	abstract[75]|abstract[77]|abstract[78]	giv[75]|giv[77]|giv[78]	_	_
14-22	1609-1614	issue	abstract[75]|abstract[77]|abstract[78]	giv[75]|giv[77]|giv[78]	_	_
14-23	1615-1618	the	abstract[75]|abstract[77]|abstract[78]|person[79]	giv[75]|giv[77]|giv[78]|giv[79]	coref	19-10[104_79]
14-24	1619-1626	patient	abstract[75]|abstract[77]|abstract[78]|person[79]	giv[75]|giv[77]|giv[78]|giv[79]	_	_
14-25	1627-1629	is	abstract[75]|abstract[77]|abstract[78]	giv[75]|giv[77]|giv[78]	_	_
14-26	1630-1639	suffering	abstract[75]|abstract[77]|abstract[78]	giv[75]|giv[77]|giv[78]	_	_
14-27	1640-1644	from	_	_	_	_
14-28	1645-1654	regarding	_	_	_	_
14-29	1655-1660	their	abstract|abstract[81]	giv|giv[81]	ana	15-1[0_81]
14-30	1661-1667	sexual	abstract[81]	giv[81]	_	_
14-31	1668-1674	health	abstract[81]	giv[81]	_	_
14-32	1675-1676	.	_	_	_	_

#Text=This may include referral to a specialist for further treatment and management .
15-1	1677-1681	This	abstract	giv	_	_
15-2	1682-1685	may	_	_	_	_
15-3	1686-1693	include	_	_	_	_
15-4	1694-1702	referral	object[83]	new[83]	_	_
15-5	1703-1705	to	object[83]	new[83]	_	_
15-6	1706-1707	a	object[83]|person[84]	new[83]|new[84]	_	_
15-7	1708-1718	specialist	object[83]|person[84]	new[83]|new[84]	_	_
15-8	1719-1722	for	object[83]|person[84]	new[83]|new[84]	_	_
15-9	1723-1730	further	object[83]|person[84]|abstract[85]	new[83]|new[84]|giv[85]	coref	33-13[203_85]
15-10	1731-1740	treatment	object[83]|person[84]|abstract[85]	new[83]|new[84]|giv[85]	_	_
15-11	1741-1744	and	object[83]|person[84]	new[83]|new[84]	_	_
15-12	1745-1755	management	object[83]|person[84]|organization	new[83]|new[84]|new	_	_
15-13	1756-1757	.	_	_	_	_

#Text=As previously discussed , confirming a diagnosis of PE requires the presence of all three components .
16-1	1758-1760	As	_	_	_	_
16-2	1761-1771	previously	_	_	_	_
16-3	1772-1781	discussed	_	_	_	_
16-4	1782-1783	,	_	_	_	_
16-5	1784-1794	confirming	_	_	_	_
16-6	1795-1796	a	abstract[87]	new[87]	coref	23-22[132_87]
16-7	1797-1806	diagnosis	abstract[87]	new[87]	_	_
16-8	1807-1809	of	abstract[87]	new[87]	_	_
16-9	1810-1812	PE	abstract[87]|abstract	new[87]|giv	coref	20-33[113_0]
16-10	1813-1821	requires	_	_	_	_
16-11	1822-1825	the	abstract[89]	new[89]	_	_
16-12	1826-1834	presence	abstract[89]	new[89]	_	_
16-13	1835-1837	of	abstract[89]	new[89]	_	_
16-14	1838-1841	all	abstract[89]|abstract[90]	new[89]|new[90]	coref	28-14[164_90]
16-15	1842-1847	three	abstract[89]|abstract[90]	new[89]|new[90]	_	_
16-16	1848-1858	components	abstract[89]|abstract[90]	new[89]|new[90]	_	_
16-17	1859-1860	.	_	_	_	_

#Text=The first relates to ejaculatory latency , with patients having an IELT of one minute or less on all or nearly all sexual encounters , or a reduction in IELT to about three minutes .
17-1	1861-1864	The	_	_	_	_
17-2	1865-1870	first	_	_	_	_
17-3	1871-1878	relates	_	_	_	_
17-4	1879-1881	to	_	_	_	_
17-5	1882-1893	ejaculatory	event[91]	new[91]	coref	31-26[0_91]
17-6	1894-1901	latency	event[91]	new[91]	_	_
17-7	1902-1903	,	_	_	_	_
17-8	1904-1908	with	_	_	_	_
17-9	1909-1917	patients	person	giv	coref	30-11[177_0]
17-10	1918-1924	having	_	_	_	_
17-11	1925-1927	an	abstract[93]	new[93]	coref	17-30[0_93]
17-12	1928-1932	IELT	abstract[93]	new[93]	_	_
17-13	1933-1935	of	abstract[93]	new[93]	_	_
17-14	1936-1939	one	abstract[93]|time[94]	new[93]|new[94]	_	_
17-15	1940-1946	minute	abstract[93]|time[94]	new[93]|new[94]	_	_
17-16	1947-1949	or	abstract[93]	new[93]	_	_
17-17	1950-1954	less	abstract[93]	new[93]	_	_
17-18	1955-1957	on	_	_	_	_
17-19	1958-1961	all	event[95]	new[95]	_	_
17-20	1962-1964	or	event[95]	new[95]	_	_
17-21	1965-1971	nearly	event[95]	new[95]	_	_
17-22	1972-1975	all	event[95]	new[95]	_	_
17-23	1976-1982	sexual	event[95]	new[95]	_	_
17-24	1983-1993	encounters	event[95]	new[95]	_	_
17-25	1994-1995	,	_	_	_	_
17-26	1996-1998	or	_	_	_	_
17-27	1999-2000	a	event[96]	new[96]	_	_
17-28	2001-2010	reduction	event[96]	new[96]	_	_
17-29	2011-2013	in	event[96]	new[96]	_	_
17-30	2014-2018	IELT	event[96]|abstract	new[96]|giv	coref	21-9
17-31	2019-2021	to	event[96]	new[96]	_	_
17-32	2022-2027	about	event[96]|time[98]	new[96]|new[98]	_	_
17-33	2028-2033	three	event[96]|time[98]	new[96]|new[98]	_	_
17-34	2034-2041	minutes	event[96]|time[98]	new[96]|new[98]	_	_
17-35	2042-2043	.	_	_	_	_

#Text=The second is a lack of control , or inability to delay ejaculation .
18-1	2044-2047	The	_	_	_	_
18-2	2048-2054	second	_	_	_	_
18-3	2055-2057	is	_	_	_	_
18-4	2058-2059	a	abstract[99]	new[99]	_	_
18-5	2060-2064	lack	abstract[99]	new[99]	_	_
18-6	2065-2067	of	abstract[99]	new[99]	_	_
18-7	2068-2075	control	abstract[99]|abstract	new[99]|new	coref	23-3[127_0]
18-8	2076-2077	,	_	_	_	_
18-9	2078-2080	or	_	_	_	_
18-10	2081-2090	inability	event[101]	new[101]	_	_
18-11	2091-2093	to	event[101]	new[101]	_	_
18-12	2094-2099	delay	event[101]	new[101]	_	_
18-13	2100-2111	ejaculation	event[101]|event	new[101]|new	coref	27-10[154_0]
18-14	2112-2113	.	_	_	_	_

#Text=Finally , there must be negative personal consequences for the patient , which may include psychological or interpersonal issues .
19-1	2114-2121	Finally	_	_	_	_
19-2	2122-2123	,	_	_	_	_
19-3	2124-2129	there	_	_	_	_
19-4	2130-2134	must	_	_	_	_
19-5	2135-2137	be	_	_	_	_
19-6	2138-2146	negative	abstract[103]	new[103]	_	_
19-7	2147-2155	personal	abstract[103]	new[103]	_	_
19-8	2156-2168	consequences	abstract[103]	new[103]	_	_
19-9	2169-2172	for	abstract[103]	new[103]	_	_
19-10	2173-2176	the	abstract[103]|person[104]	new[103]|giv[104]	coref	20-9[107_104]
19-11	2177-2184	patient	abstract[103]|person[104]	new[103]|giv[104]	_	_
19-12	2185-2186	,	abstract[103]	new[103]	_	_
19-13	2187-2192	which	abstract[103]	new[103]	_	_
19-14	2193-2196	may	abstract[103]	new[103]	_	_
19-15	2197-2204	include	abstract[103]	new[103]	_	_
19-16	2205-2218	psychological	abstract[103]|abstract[105]	new[103]|new[105]	_	_
19-17	2219-2221	or	abstract[103]|abstract[105]	new[103]|new[105]	_	_
19-18	2222-2235	interpersonal	abstract[103]|abstract[105]	new[103]|new[105]	_	_
19-19	2236-2242	issues	abstract[103]|abstract[105]	new[103]|new[105]	_	_
19-20	2243-2244	.	_	_	_	_

#Text=As such , clinicians must primarily explore the patient ’s sexual history ; however a full medical history , psychological history and a physical exam is often necessary to provide context surrounding the PE and to consider possible underlying causes of acquired PE .
20-1	2245-2247	As	_	_	_	_
20-2	2248-2252	such	_	_	_	_
20-3	2253-2254	,	_	_	_	_
20-4	2255-2265	clinicians	person	giv	_	_
20-5	2266-2270	must	_	_	_	_
20-6	2271-2280	primarily	_	_	_	_
20-7	2281-2288	explore	_	_	_	_
20-8	2289-2292	the	abstract[108]	new[108]	coref	20-15[109_108]
20-9	2293-2300	patient	person[107]|abstract[108]	giv[107]|new[108]	coref	23-10[0_107]
20-10	2301-2303	’s	person[107]|abstract[108]	giv[107]|new[108]	_	_
20-11	2304-2310	sexual	abstract[108]	new[108]	_	_
20-12	2311-2318	history	abstract[108]	new[108]	_	_
20-13	2319-2320	;	_	_	_	_
20-14	2321-2328	however	_	_	_	_
20-15	2329-2330	a	abstract[109]	giv[109]	coref	20-20[110_109]
20-16	2331-2335	full	abstract[109]	giv[109]	_	_
20-17	2336-2343	medical	abstract[109]	giv[109]	_	_
20-18	2344-2351	history	abstract[109]	giv[109]	_	_
20-19	2352-2353	,	_	_	_	_
20-20	2354-2367	psychological	abstract[110]	giv[110]	coref	21-1[116_110]
20-21	2368-2375	history	abstract[110]	giv[110]	_	_
20-22	2376-2379	and	_	_	_	_
20-23	2380-2381	a	abstract[111]	new[111]	_	_
20-24	2382-2390	physical	abstract[111]	new[111]	_	_
20-25	2391-2395	exam	abstract[111]	new[111]	_	_
20-26	2396-2398	is	_	_	_	_
20-27	2399-2404	often	_	_	_	_
20-28	2405-2414	necessary	_	_	_	_
20-29	2415-2417	to	_	_	_	_
20-30	2418-2425	provide	_	_	_	_
20-31	2426-2433	context	abstract[112]	new[112]	_	_
20-32	2434-2445	surrounding	abstract[112]	new[112]	_	_
20-33	2446-2449	the	abstract[112]|abstract[113]	new[112]|giv[113]	coref	20-42[115_113]
20-34	2450-2452	PE	abstract[112]|abstract[113]	new[112]|giv[113]	_	_
20-35	2453-2456	and	_	_	_	_
20-36	2457-2459	to	_	_	_	_
20-37	2460-2468	consider	_	_	_	_
20-38	2469-2477	possible	abstract[114]	new[114]	_	_
20-39	2478-2488	underlying	abstract[114]	new[114]	_	_
20-40	2489-2495	causes	abstract[114]	new[114]	_	_
20-41	2496-2498	of	abstract[114]	new[114]	_	_
20-42	2499-2507	acquired	abstract[114]|abstract[115]	new[114]|giv[115]	coref	21-19[0_115]
20-43	2508-2510	PE	abstract[114]|abstract[115]	new[114]|giv[115]	_	_
20-44	2511-2512	.	_	_	_	_

#Text=The sexual history should involve an estimate of IELT , as well as the onset and duration of PE .
21-1	2513-2516	The	abstract[116]	giv[116]	coref	22-5[123_116]
21-2	2517-2523	sexual	abstract[116]	giv[116]	_	_
21-3	2524-2531	history	abstract[116]	giv[116]	_	_
21-4	2532-2538	should	_	_	_	_
21-5	2539-2546	involve	_	_	_	_
21-6	2547-2549	an	abstract[117]	new[117]	_	_
21-7	2550-2558	estimate	abstract[117]	new[117]	_	_
21-8	2559-2561	of	abstract[117]	new[117]	_	_
21-9	2562-2566	IELT	abstract[117]|abstract	new[117]|giv	coref	31-5
21-10	2567-2568	,	_	_	_	_
21-11	2569-2571	as	_	_	_	_
21-12	2572-2576	well	_	_	_	_
21-13	2577-2579	as	_	_	_	_
21-14	2580-2583	the	event[119]	new[119]	_	_
21-15	2584-2589	onset	event[119]	new[119]	_	_
21-16	2590-2593	and	_	_	_	_
21-17	2594-2602	duration	time[120]	new[120]	_	_
21-18	2603-2605	of	time[120]	new[120]	_	_
21-19	2606-2608	PE	time[120]|abstract	new[120]|giv	coref	22-16[125_0]
21-20	2609-2610	.	_	_	_	_

#Text=Previous sexual functioning and history of sexual relations are also necessary in order to delineate acquired and lifelong PE .
22-1	2611-2619	Previous	abstract[122]	new[122]	_	_
22-2	2620-2626	sexual	abstract[122]	new[122]	_	_
22-3	2627-2638	functioning	abstract[122]	new[122]	_	_
22-4	2639-2642	and	_	_	_	_
22-5	2643-2650	history	abstract[123]	giv[123]	coref	24-1[134_123]
22-6	2651-2653	of	abstract[123]	giv[123]	_	_
22-7	2654-2660	sexual	abstract[123]|abstract[124]	giv[123]|new[124]	_	_
22-8	2661-2670	relations	abstract[123]|abstract[124]	giv[123]|new[124]	_	_
22-9	2671-2674	are	_	_	_	_
22-10	2675-2679	also	_	_	_	_
22-11	2680-2689	necessary	_	_	_	_
22-12	2690-2692	in	_	_	_	_
22-13	2693-2698	order	_	_	_	_
22-14	2699-2701	to	_	_	_	_
22-15	2702-2711	delineate	_	_	_	_
22-16	2712-2720	acquired	abstract[125]	giv[125]	coref	23-25[0_125]
22-17	2721-2724	and	abstract[125]	giv[125]	_	_
22-18	2725-2733	lifelong	abstract[125]	giv[125]	_	_
22-19	2734-2736	PE	abstract[125]	giv[125]	_	_
22-20	2737-2738	.	_	_	_	_

#Text=Degree of ejaculatory control as well as degree of patient and partner distress should also be ascertained in order to fulfil a diagnosis of PE .
23-1	2739-2745	Degree	abstract[126]	new[126]	_	_
23-2	2746-2748	of	abstract[126]	new[126]	_	_
23-3	2749-2760	ejaculatory	abstract[126]|abstract[127]	new[126]|giv[127]	coref	35-10[213_127]
23-4	2761-2768	control	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
23-5	2769-2771	as	_	_	_	_
23-6	2772-2776	well	_	_	_	_
23-7	2777-2779	as	_	_	_	_
23-8	2780-2786	degree	abstract[128]	new[128]	_	_
23-9	2787-2789	of	abstract[128]	new[128]	_	_
23-10	2790-2797	patient	abstract[128]|person|abstract[131]	new[128]|giv|new[131]	coref|coref	25-4|35-21[217_131]
23-11	2798-2801	and	abstract[128]|abstract[131]	new[128]|new[131]	_	_
23-12	2802-2809	partner	abstract[128]|person|abstract[131]	new[128]|new|new[131]	_	_
23-13	2810-2818	distress	abstract[128]|abstract[131]	new[128]|new[131]	_	_
23-14	2819-2825	should	_	_	_	_
23-15	2826-2830	also	_	_	_	_
23-16	2831-2833	be	_	_	_	_
23-17	2834-2845	ascertained	_	_	_	_
23-18	2846-2848	in	_	_	_	_
23-19	2849-2854	order	_	_	_	_
23-20	2855-2857	to	_	_	_	_
23-21	2858-2864	fulfil	_	_	_	_
23-22	2865-2866	a	abstract[132]	giv[132]	_	_
23-23	2867-2876	diagnosis	abstract[132]	giv[132]	_	_
23-24	2877-2879	of	abstract[132]	giv[132]	_	_
23-25	2880-2882	PE	abstract[132]|abstract	giv[132]|giv	coref	24-20[138_0]
23-26	2883-2884	.	_	_	_	_

#Text=A psychological history is also important in order to assess the likelihood of a psychological cause or association with the PE .
24-1	2885-2886	A	abstract[134]	giv[134]	_	_
24-2	2887-2900	psychological	abstract[134]	giv[134]	_	_
24-3	2901-2908	history	abstract[134]	giv[134]	_	_
24-4	2909-2911	is	_	_	_	_
24-5	2912-2916	also	_	_	_	_
24-6	2917-2926	important	_	_	_	_
24-7	2927-2929	in	_	_	_	_
24-8	2930-2935	order	_	_	_	_
24-9	2936-2938	to	_	_	_	_
24-10	2939-2945	assess	_	_	_	_
24-11	2946-2949	the	abstract[135]	new[135]	_	_
24-12	2950-2960	likelihood	abstract[135]	new[135]	_	_
24-13	2961-2963	of	abstract[135]	new[135]	_	_
24-14	2964-2965	a	abstract[135]|abstract[136]	new[135]|new[136]	_	_
24-15	2966-2979	psychological	abstract[135]|abstract[136]	new[135]|new[136]	_	_
24-16	2980-2985	cause	abstract[135]|abstract[136]	new[135]|new[136]	_	_
24-17	2986-2988	or	abstract[135]	new[135]	_	_
24-18	2989-3000	association	abstract[135]|abstract[137]	new[135]|new[137]	_	_
24-19	3001-3005	with	abstract[135]|abstract[137]	new[135]|new[137]	_	_
24-20	3006-3009	the	abstract[135]|abstract[137]|abstract[138]	new[135]|new[137]|giv[138]	ana	25-1[0_138]
24-21	3010-3012	PE	abstract[135]|abstract[137]|abstract[138]	new[135]|new[137]|giv[138]	_	_
24-22	3013-3014	.	_	_	_	_

#Text=This includes identifying patient stressors , as well as assessing a history/presence of anxiety or depression .
25-1	3015-3019	This	abstract	giv	coref	26-12
25-2	3020-3028	includes	_	_	_	_
25-3	3029-3040	identifying	_	_	_	_
25-4	3041-3048	patient	person|abstract[141]	giv|new[141]	coref	30-7
25-5	3049-3058	stressors	abstract[141]	new[141]	_	_
25-6	3059-3060	,	_	_	_	_
25-7	3061-3063	as	_	_	_	_
25-8	3064-3068	well	_	_	_	_
25-9	3069-3071	as	_	_	_	_
25-10	3072-3081	assessing	_	_	_	_
25-11	3082-3083	a	abstract[142]	new[142]	_	_
25-12	3084-3100	history/presence	abstract[142]	new[142]	_	_
25-13	3101-3103	of	abstract[142]	new[142]	_	_
25-14	3104-3111	anxiety	abstract[142]|abstract	new[142]|new	_	_
25-15	3112-3114	or	abstract[142]	new[142]	_	_
25-16	3115-3125	depression	abstract[142]|abstract	new[142]|new	_	_
25-17	3126-3127	.	_	_	_	_

#Text=A focused physical examination can point towards an underlying cause of PE and this may include a genitourinary examination and neurological assessment of the lower limbs .
26-1	3128-3129	A	event[145]	new[145]	coref	26-17[149_145]
26-2	3130-3137	focused	event[145]	new[145]	_	_
26-3	3138-3146	physical	event[145]	new[145]	_	_
26-4	3147-3158	examination	event[145]	new[145]	_	_
26-5	3159-3162	can	_	_	_	_
26-6	3163-3168	point	_	_	_	_
26-7	3169-3176	towards	_	_	_	_
26-8	3177-3179	an	abstract[146]	new[146]	_	_
26-9	3180-3190	underlying	abstract[146]	new[146]	_	_
26-10	3191-3196	cause	abstract[146]	new[146]	_	_
26-11	3197-3199	of	abstract[146]	new[146]	_	_
26-12	3200-3202	PE	abstract[146]|abstract	new[146]|giv	ana	26-14
26-13	3203-3206	and	_	_	_	_
26-14	3207-3211	this	abstract	giv	coref	29-14[168_0]
26-15	3212-3215	may	_	_	_	_
26-16	3216-3223	include	_	_	_	_
26-17	3224-3225	a	event[149]	giv[149]	_	_
26-18	3226-3239	genitourinary	event[149]	giv[149]	_	_
26-19	3240-3251	examination	event[149]	giv[149]	_	_
26-20	3252-3255	and	_	_	_	_
26-21	3256-3268	neurological	abstract[150]	new[150]	_	_
26-22	3269-3279	assessment	abstract[150]	new[150]	_	_
26-23	3280-3282	of	abstract[150]	new[150]	_	_
26-24	3283-3286	the	abstract[150]|object[151]	new[150]|new[151]	_	_
26-25	3287-3292	lower	abstract[150]|object[151]	new[150]|new[151]	_	_
26-26	3293-3298	limbs	abstract[150]|object[151]	new[150]|new[151]	_	_
26-27	3299-3300	.	_	_	_	_

#Text=A common diagnostic tool used in the assessment of premature ejaculation is the premature ejaculation diagnostic tool ( PEDT ) developed by Symonds et al. .
27-1	3301-3302	A	abstract[152]	new[152]	coref	27-13[156_152]
27-2	3303-3309	common	abstract[152]	new[152]	_	_
27-3	3310-3320	diagnostic	abstract[152]	new[152]	_	_
27-4	3321-3325	tool	abstract[152]	new[152]	_	_
27-5	3326-3330	used	abstract[152]	new[152]	_	_
27-6	3331-3333	in	abstract[152]	new[152]	_	_
27-7	3334-3337	the	abstract[152]|abstract[153]	new[152]|new[153]	_	_
27-8	3338-3348	assessment	abstract[152]|abstract[153]	new[152]|new[153]	_	_
27-9	3349-3351	of	abstract[152]|abstract[153]	new[152]|new[153]	_	_
27-10	3352-3361	premature	abstract[152]|abstract[153]|event[154]	new[152]|new[153]|giv[154]	coref	27-14[155_154]
27-11	3362-3373	ejaculation	abstract[152]|abstract[153]|event[154]	new[152]|new[153]|giv[154]	_	_
27-12	3374-3376	is	_	_	_	_
27-13	3377-3380	the	abstract[156]	giv[156]	appos	27-19[0_156]
27-14	3381-3390	premature	event[155]|abstract[156]	giv[155]|giv[156]	coref	28-10[163_155]
27-15	3391-3402	ejaculation	event[155]|abstract[156]	giv[155]|giv[156]	_	_
27-16	3403-3413	diagnostic	abstract[156]	giv[156]	_	_
27-17	3414-3418	tool	abstract[156]	giv[156]	_	_
27-18	3419-3420	(	_	_	_	_
27-19	3421-3425	PEDT	abstract	giv	coref	28-1[159_0]
27-20	3426-3427	)	_	_	_	_
27-21	3428-3437	developed	_	_	_	_
27-22	3438-3440	by	_	_	_	_
27-23	3441-3448	Symonds	person	new	_	_
27-24	3449-3451	et	_	_	_	_
27-25	3452-3455	al.	_	_	_	_
27-26	3456-3457	.	_	_	_	_

#Text=The tool asks questions regarding the ISSM criteria of premature ejaculation to cover all three components of the definition .
28-1	3458-3461	The	abstract[159]	giv[159]	coref	29-8[167_159]
28-2	3462-3466	tool	abstract[159]	giv[159]	_	_
28-3	3467-3471	asks	_	_	_	_
28-4	3472-3481	questions	abstract[160]	new[160]	_	_
28-5	3482-3491	regarding	abstract[160]	new[160]	_	_
28-6	3492-3495	the	abstract[160]|abstract[162]	new[160]|new[162]	_	_
28-7	3496-3500	ISSM	abstract[160]|abstract|abstract[162]	new[160]|new|new[162]	_	_
28-8	3501-3509	criteria	abstract[160]|abstract[162]	new[160]|new[162]	_	_
28-9	3510-3512	of	abstract[160]|abstract[162]	new[160]|new[162]	_	_
28-10	3513-3522	premature	abstract[160]|abstract[162]|event[163]	new[160]|new[162]|giv[163]	coref	35-12[0_163]
28-11	3523-3534	ejaculation	abstract[160]|abstract[162]|event[163]	new[160]|new[162]|giv[163]	_	_
28-12	3535-3537	to	_	_	_	_
28-13	3538-3543	cover	_	_	_	_
28-14	3544-3547	all	abstract[164]	giv[164]	_	_
28-15	3548-3553	three	abstract[164]	giv[164]	_	_
28-16	3554-3564	components	abstract[164]	giv[164]	_	_
28-17	3565-3567	of	abstract[164]	giv[164]	_	_
28-18	3568-3571	the	abstract[164]|abstract[165]	giv[164]|new[165]	ana	29-1[0_165]
28-19	3572-3582	definition	abstract[164]|abstract[165]	giv[164]|new[165]	_	_
28-20	3583-3584	.	_	_	_	_

#Text=It is important to note however that the tool fails to distinguish between acquired and lifelong PE , and as such , involvement by the clinician is important in the identification of the correct PE subtype .
29-1	3585-3587	It	abstract	giv	_	_
29-2	3588-3590	is	_	_	_	_
29-3	3591-3600	important	_	_	_	_
29-4	3601-3603	to	_	_	_	_
29-5	3604-3608	note	_	_	_	_
29-6	3609-3616	however	_	_	_	_
29-7	3617-3621	that	_	_	_	_
29-8	3622-3625	the	abstract[167]	giv[167]	_	_
29-9	3626-3630	tool	abstract[167]	giv[167]	_	_
29-10	3631-3636	fails	_	_	_	_
29-11	3637-3639	to	_	_	_	_
29-12	3640-3651	distinguish	_	_	_	_
29-13	3652-3659	between	_	_	_	_
29-14	3660-3668	acquired	abstract[168]	giv[168]	coref	29-35[0_168]
29-15	3669-3672	and	abstract[168]	giv[168]	_	_
29-16	3673-3681	lifelong	abstract[168]	giv[168]	_	_
29-17	3682-3684	PE	abstract[168]	giv[168]	_	_
29-18	3685-3686	,	_	_	_	_
29-19	3687-3690	and	_	_	_	_
29-20	3691-3693	as	_	_	_	_
29-21	3694-3698	such	_	_	_	_
29-22	3699-3700	,	_	_	_	_
29-23	3701-3712	involvement	abstract[169]	new[169]	_	_
29-24	3713-3715	by	abstract[169]	new[169]	_	_
29-25	3716-3719	the	abstract[169]|person[170]	new[169]|giv[170]	_	_
29-26	3720-3729	clinician	abstract[169]|person[170]	new[169]|giv[170]	_	_
29-27	3730-3732	is	_	_	_	_
29-28	3733-3742	important	_	_	_	_
29-29	3743-3745	in	_	_	_	_
29-30	3746-3749	the	abstract[171]	new[171]	_	_
29-31	3750-3764	identification	abstract[171]	new[171]	_	_
29-32	3765-3767	of	abstract[171]	new[171]	_	_
29-33	3768-3771	the	abstract[171]|abstract[173]	new[171]|new[173]	ana	30-1[0_173]
29-34	3772-3779	correct	abstract[171]|abstract[173]	new[171]|new[173]	_	_
29-35	3780-3782	PE	abstract[171]|abstract|abstract[173]	new[171]|giv|new[173]	coref	30-13
29-36	3783-3790	subtype	abstract[171]|abstract[173]	new[171]|new[173]	_	_
29-37	3791-3792	.	_	_	_	_

#Text=It is also crucial to manage patient expectations when assessing patients with PE .
30-1	3793-3795	It	abstract	giv	_	_
30-2	3796-3798	is	_	_	_	_
30-3	3799-3803	also	_	_	_	_
30-4	3804-3811	crucial	_	_	_	_
30-5	3812-3814	to	_	_	_	_
30-6	3815-3821	manage	_	_	_	_
30-7	3822-3829	patient	person|abstract[176]	giv|new[176]	coref|coref	32-25[197_176]|33-6
30-8	3830-3842	expectations	abstract[176]	new[176]	_	_
30-9	3843-3847	when	_	_	_	_
30-10	3848-3857	assessing	_	_	_	_
30-11	3858-3866	patients	person[177]	giv[177]	coref	32-1[190_177]
30-12	3867-3871	with	person[177]	giv[177]	_	_
30-13	3872-3874	PE	person[177]|abstract	giv[177]|giv	coref	35-25
30-14	3875-3876	.	_	_	_	_

#Text=Waldinger et al. found IELT to vary in a population of men with partners >6 months from 0.55 – 44.1 min , with a median latency time of 5.4 min .
31-1	3877-3886	Waldinger	person	new	_	_
31-2	3887-3889	et	_	_	_	_
31-3	3890-3893	al.	_	_	_	_
31-4	3894-3899	found	_	_	_	_
31-5	3900-3904	IELT	abstract	giv	coref	32-10
31-6	3905-3907	to	_	_	_	_
31-7	3908-3912	vary	_	_	_	_
31-8	3913-3915	in	_	_	_	_
31-9	3916-3917	a	person[181]	new[181]	_	_
31-10	3918-3928	population	person[181]	new[181]	_	_
31-11	3929-3931	of	person[181]	new[181]	_	_
31-12	3932-3935	men	person[181]|person[182]	new[181]|new[182]	_	_
31-13	3936-3940	with	person[181]|person[182]	new[181]|new[182]	_	_
31-14	3941-3949	partners	person[181]|person[182]|person[183]	new[181]|new[182]|new[183]	coref	32-4[0_183]
31-15	3950-3952	>6	person[181]|person[182]|person[183]|time[184]	new[181]|new[182]|new[183]|new[184]	_	_
31-16	3953-3959	months	person[181]|person[182]|person[183]|time[184]	new[181]|new[182]|new[183]|new[184]	_	_
31-17	3960-3964	from	_	_	_	_
31-18	3965-3969	0.55	time[186]	new[186]	_	_
31-19	3970-3971	–	time[186]	new[186]	_	_
31-20	3972-3976	44.1	abstract|time[186]	new|new[186]	_	_
31-21	3977-3980	min	time[186]	new[186]	_	_
31-22	3981-3982	,	_	_	_	_
31-23	3983-3987	with	_	_	_	_
31-24	3988-3989	a	time[188]	new[188]	_	_
31-25	3990-3996	median	time[188]	new[188]	_	_
31-26	3997-4004	latency	event|time[188]	giv|new[188]	coref	32-19
31-27	4005-4009	time	time[188]	new[188]	_	_
31-28	4010-4012	of	time[188]	new[188]	_	_
31-29	4013-4016	5.4	time[188]|time[189]	new[188]|new[189]	_	_
31-30	4017-4020	min	time[188]|time[189]	new[188]|new[189]	_	_
31-31	4021-4022	.	_	_	_	_

#Text=Some patients and/or partners may have preconceived perceptions about IELT that are well in excess of this median latency time and may consequently have unrealistic expectations of what can be achieved with therapy .
32-1	4023-4027	Some	person[190]|person[191]	giv[190]|giv[191]	coref	32-1[191_190]
32-2	4028-4036	patients	person[190]|person[191]	giv[190]|giv[191]	_	_
32-3	4037-4043	and/or	person[191]	giv[191]	_	_
32-4	4044-4052	partners	person[191]|person	giv[191]|giv	_	_
32-5	4053-4056	may	_	_	_	_
32-6	4057-4061	have	_	_	_	_
32-7	4062-4074	preconceived	abstract[193]	new[193]	_	_
32-8	4075-4086	perceptions	abstract[193]	new[193]	_	_
32-9	4087-4092	about	abstract[193]	new[193]	_	_
32-10	4093-4097	IELT	abstract[193]|abstract	new[193]|giv	coref	35-7
32-11	4098-4102	that	abstract[193]	new[193]	_	_
32-12	4103-4106	are	abstract[193]	new[193]	_	_
32-13	4107-4111	well	abstract[193]	new[193]	_	_
32-14	4112-4114	in	abstract[193]	new[193]	_	_
32-15	4115-4121	excess	abstract[193]	new[193]	_	_
32-16	4122-4124	of	abstract[193]	new[193]	_	_
32-17	4125-4129	this	abstract[193]|time[196]	new[193]|new[196]	_	_
32-18	4130-4136	median	abstract[193]|time[196]	new[193]|new[196]	_	_
32-19	4137-4144	latency	abstract[193]|event|time[196]	new[193]|giv|new[196]	_	_
32-20	4145-4149	time	abstract[193]|time[196]	new[193]|new[196]	_	_
32-21	4150-4153	and	_	_	_	_
32-22	4154-4157	may	_	_	_	_
32-23	4158-4170	consequently	_	_	_	_
32-24	4171-4175	have	_	_	_	_
32-25	4176-4187	unrealistic	abstract[197]	giv[197]	coref	33-6[201_197]
32-26	4188-4200	expectations	abstract[197]	giv[197]	_	_
32-27	4201-4203	of	abstract[197]	giv[197]	_	_
32-28	4204-4208	what	abstract[197]	giv[197]	_	_
32-29	4209-4212	can	abstract[197]	giv[197]	_	_
32-30	4213-4215	be	abstract[197]	giv[197]	_	_
32-31	4216-4224	achieved	abstract[197]	giv[197]	_	_
32-32	4225-4229	with	abstract[197]	giv[197]	_	_
32-33	4230-4237	therapy	abstract[197]|abstract	giv[197]|giv	_	_
32-34	4238-4239	.	_	_	_	_

#Text=By gaining an understanding of patient expectations concerning therapeutic outcomes , initiating suitable treatment , or modifying current treatment , can be appropriately managed .
33-1	4240-4242	By	_	_	_	_
33-2	4243-4250	gaining	_	_	_	_
33-3	4251-4253	an	abstract[199]	new[199]	_	_
33-4	4254-4267	understanding	abstract[199]	new[199]	_	_
33-5	4268-4270	of	abstract[199]	new[199]	_	_
33-6	4271-4278	patient	abstract[199]|person|abstract[201]	new[199]|giv|giv[201]	coref	34-11[208_0]
33-7	4279-4291	expectations	abstract[199]|abstract[201]	new[199]|giv[201]	_	_
33-8	4292-4302	concerning	abstract[199]|abstract[201]	new[199]|giv[201]	_	_
33-9	4303-4314	therapeutic	abstract[199]|abstract[201]|abstract[202]	new[199]|giv[201]|new[202]	_	_
33-10	4315-4323	outcomes	abstract[199]|abstract[201]|abstract[202]	new[199]|giv[201]|new[202]	_	_
33-11	4324-4325	,	_	_	_	_
33-12	4326-4336	initiating	_	_	_	_
33-13	4337-4345	suitable	abstract[203]	giv[203]	coref	33-18[204_203]
33-14	4346-4355	treatment	abstract[203]	giv[203]	_	_
33-15	4356-4357	,	_	_	_	_
33-16	4358-4360	or	_	_	_	_
33-17	4361-4370	modifying	_	_	_	_
33-18	4371-4378	current	abstract[204]	giv[204]	ana	34-1[0_204]
33-19	4379-4388	treatment	abstract[204]	giv[204]	_	_
33-20	4389-4390	,	_	_	_	_
33-21	4391-4394	can	_	_	_	_
33-22	4395-4397	be	_	_	_	_
33-23	4398-4411	appropriately	_	_	_	_
33-24	4412-4419	managed	_	_	_	_
33-25	4420-4421	.	_	_	_	_

#Text=This is best achieved by setting achievable treatment goals with the patient .
34-1	4422-4426	This	abstract	giv	coref	34-8
34-2	4427-4429	is	_	_	_	_
34-3	4430-4434	best	_	_	_	_
34-4	4435-4443	achieved	_	_	_	_
34-5	4444-4446	by	_	_	_	_
34-6	4447-4454	setting	_	_	_	_
34-7	4455-4465	achievable	abstract[207]	new[207]	coref	35-3[211_207]
34-8	4466-4475	treatment	abstract|abstract[207]	giv|new[207]	coref	35-3
34-9	4476-4481	goals	abstract[207]	new[207]	_	_
34-10	4482-4486	with	_	_	_	_
34-11	4487-4490	the	person[208]	giv[208]	_	_
34-12	4491-4498	patient	person[208]	giv[208]	_	_
34-13	4499-4500	.	_	_	_	_

#Text=Examples of treatment goals include increasing IELT , increasing control over ejaculation , increasing satisfaction with sexual intercourse and decreasing personal distress related to PE .
35-1	4501-4509	Examples	abstract[209]	new[209]	_	_
35-2	4510-4512	of	abstract[209]	new[209]	_	_
35-3	4513-4522	treatment	abstract[209]|abstract|abstract[211]	new[209]|giv|giv[211]	_	_
35-4	4523-4528	goals	abstract[209]|abstract[211]	new[209]|giv[211]	_	_
35-5	4529-4536	include	_	_	_	_
35-6	4537-4547	increasing	_	_	_	_
35-7	4548-4552	IELT	abstract	giv	_	_
35-8	4553-4554	,	_	_	_	_
35-9	4555-4565	increasing	_	_	_	_
35-10	4566-4573	control	abstract[213]	giv[213]	_	_
35-11	4574-4578	over	abstract[213]	giv[213]	_	_
35-12	4579-4590	ejaculation	abstract[213]|event	giv[213]|giv	_	_
35-13	4591-4592	,	_	_	_	_
35-14	4593-4603	increasing	_	_	_	_
35-15	4604-4616	satisfaction	abstract[215]	new[215]	_	_
35-16	4617-4621	with	abstract[215]	new[215]	_	_
35-17	4622-4628	sexual	abstract[215]|event[216]	new[215]|new[216]	_	_
35-18	4629-4640	intercourse	abstract[215]|event[216]	new[215]|new[216]	_	_
35-19	4641-4644	and	_	_	_	_
35-20	4645-4655	decreasing	_	_	_	_
35-21	4656-4664	personal	abstract[217]	giv[217]	_	_
35-22	4665-4673	distress	abstract[217]	giv[217]	_	_
35-23	4674-4681	related	abstract[217]	giv[217]	_	_
35-24	4682-4684	to	abstract[217]	giv[217]	_	_
35-25	4685-4687	PE	abstract[217]|abstract	giv[217]|giv	_	_
35-26	4688-4689	.	_	_	_	_
